MEDiSTRAVA, an Inizio Company’s Post

We are spearheading a bold new movement. Together, we can reshape the future of healthcare.  https://lnkd.in/dNkzuU6P.

Yesterday, the MEDiSTRAVA Strategic Communications team attended the BioIndustry Association (BIA) Summer Party. It was a great evening of networking and discussing the latest innovations in the life sciences sector. We appreciated the opportunity to connect with industry peers, exchange ideas, and explore potential partnerships. Thank you to the BIA for organising such an excellent event. We look forward to future opportunities to engage with this dynamic community. #LifeSciences #BIA #Networking #Innovation #BIAsummerparty

Congratulations to our client Abingworth, which co-led Myricx Bio’s impressive £90m ($114m) Series A funding round, one of the largest early stage raises ever by a biopharma company in Europe.

Dive into AnaMaria-Corina Afuza's latest article on the Challenges and Innovations in Psychopharmacology Trials. Discover the cutting-edge advancements and the hurdles the industry is overcoming to push the boundaries of mental health treatment. Read now and stay ahead in the field! https://lnkd.in/eBWy5bdH. #Psychopharmacology #ClinicalTrials #Innovation #MedComms #MentalHealth #PharmaInnovation

We’re looking forward to attending the BioIndustry Association (BIA)’s Summer Party next week, at the Langham Hotel in London. Come and say hello to our team! 👋 Frazer Hall Sandi Greenwood Leila Adlam #BIA #Networking #MedComms

On Monday, Sylvie Berrebi was invited to attend the inspiring France Biotech event featuring a thought-provoking ESG round table discussion. 🌍 The discussions on environmental, social, and governance responsibilities were truly insightful, reaffirming the commitment to sustainable practices in Life Sciences. At MEDiSTRAVA our corporate communication team actively supports French biotech companies and their leaders in their pursuit of life science innovations. A big thank you to France Biotech for organising the event! Looking forward to continuing these important conversations and collaborations. #ESG #Sustainability #Biotechnology #FranceBiotech #Networking

We at MEDiSTRAVA were honoured to sponsor the Media Commentator Award at this year’s European Mediscience Awards 2024, celebrating outstanding commentary in the life science sector. It was a privilege to host a table including highly regarded and experienced industry journalists, including Melanie Senior from Nature Biotechnology/Evaluate/In Vivo, Ayisha Sharma from Endpoints News, and Amy Brown, who was announced shortly after the event as the new UK anchor for BiotechTV.   BiotechTV’s founder and host Brad Loncar was the winner of this year’s Media Commentator Award, and Amy joins the rapidly growing BiotechTV team to bring sector insights from interviews with CEOs from the most exciting emerging biopharma companies in the UK and beyond.   We’d like to congratulate Amy on this exciting new role and look forward to seeing her contributions to BiotechTV!   #MediscienceAwards #MediaCommentator #BiotechTV

Many congratulations to Brad Loncar of BiotechTV who won Media Commentator of the Year 2024 at this year’s European Mediscience Awards 2024 dinner, which was held last night in London. As proud sponsor of the Media Commentator Award, we appreciate the importance of highlighting and celebrating those who bring insightful comment and elevate the conversation in our industry. The European Mediscience Awards is the largest annual gathering of the biotech and life sciences community in Europe to recognise company and individual achievements in our industry. Our congratulations go to all the other award winners and to those shortlisted. #MediscienceAwards #MediaCommentator

#8 on the MM+M Agency 100! Huge thanks to our team & partners. https://lnkd.in/e8m-eZ4s #MMMAgency100 #InizioMedical #HealthcareExcellence #Innovation

We are thrilled to announce that our client, Amber Therapeutics, has successfully closed a $100 Million Series A financing round. This significant milestone will propel the development of their groundbreaking Amber-UI Neuromodulation Therapy towards US FDA approval and we're proud to support them on this transformative journey. The news has already garnered attention from leading trade journals, including Endpoints News, FirstWord HealthTech, Fierce Biotech and BioWorld News, highlighting the immense potential and impact of this breakthrough therapy. Read the full press release: https://lnkd.in/ecySTVpg #SeriesAFunding #Neuromodulation #MedicalInnovation